AZD-1480 T3069
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AZD1480 is a novel ATP-competitive JAK2 inhibitor (IC50: 0.26 nM), selectivity act against Tyk2 and JAK3, and to a smaller extent against JAK1. AZD1480 has been used in trials studying the treatment of Solid Malignancies, Post-Polycythaemia Vera, Primary
CAS nr:
935666-88-9
Purity:
98%
Molecular Weight:
348,77
SMILES:
C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1
Formula:
C14H14ClFN8
Pathway:
Angiogenesis,JAK/STAT signaling,Chromatin/Epigenetic,Stem Cells
Target:
JAK,JAK,JAK,JAK
